End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.980 CNY | +0.14% |
|
+11.15% | +56.15% |
02:08am | Jinhe Biotechnology Forecasts Up to 55% Rise in H1 Profit; Shares Up 4% | MT |
May. 16 | Jinhe Biotechnology's Controlling Shareholder To Unload Up To 3% Stake | RE |
Capitalization | 5.25B 732M 626M 583M 543M 1B 62.84B 1.11B 6.99B 2.67B 29.42B 2.75B 2.69B 108B | P/E ratio 2025 * |
29.1x | P/E ratio 2026 * | 23.3x |
---|---|---|---|---|---|
Enterprise value | 5.25B 732M 626M 583M 543M 1B 62.84B 1.11B 6.99B 2.67B 29.42B 2.75B 2.69B 108B | EV / Sales 2025 * |
2.1x | EV / Sales 2026 * | 1.91x |
Free-Float |
54.38% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
1 day | +0.14% | ||
1 week | +11.15% | ||
Current month | +12.40% | ||
1 month | +5.12% | ||
3 months | -8.76% | ||
6 months | +73.63% | ||
Current year | +56.15% |
1 week | 6.55 | ![]() | 7.05 |
1 month | 6.06 | ![]() | 7.05 |
Current year | 3.89 | ![]() | 8.69 |
1 year | 3.4 | ![]() | 8.69 |
3 years | 2.91 | ![]() | 8.69 |
5 years | 2.91 | ![]() | 9.49 |
10 years | 2.91 | ![]() | 13.28 |
Manager | Title | Age | Since |
---|---|---|---|
Chang Xian Xie
CEO | Chief Executive Officer | 63 | 2007-11-26 |
You Shan Niu
DFI | Director of Finance/CFO | 54 | 2014-08-06 |
Zhi Jun Wang
PRN | Corporate Officer/Principal | 51 | - |
Director | Title | Age | Since |
---|---|---|---|
Dong Xiao Wang
CHM | Chairman | 73 | 2007-11-26 |
Fu Zhong Li
BRD | Director/Board Member | 61 | 2007-11-26 |
Chang Xian Xie
BRD | Director/Board Member | 63 | 2007-11-26 |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+0.14% | +11.15% | +86.13% | +46.03% | 732M | ||
-2.42% | -2.65% | -13.45% | -7.66% | 68.99B | ||
-0.93% | +1.78% | +7.89% | -24.37% | 7.4B | ||
+0.62% | +1.34% | -8.41% | +4.81% | 3.67B | ||
+0.73% | +3.46% | -7.04% | -2.00% | 3.34B | ||
+0.50% | +0.67% | +18.26% | +1.20% | 2.3B | ||
-1.09% | +10.00% | +76.20% | +58.68% | 1.25B | ||
+1.34% | -0.30% | +48.27% | +13.64% | 1.25B | ||
+0.13% | +4.41% | -21.19% | -34.26% | 1.08B | ||
+1.35% | +2.87% | +10.09% | -37.97% | 1.07B | ||
Average | +0.39% | +1.96% | +19.67% | +1.81% | 9.11B | |
Weighted average by Cap. | +0.92% | -1.57% | -7.41% | -7.12% |
2025 * | 2026 * | |
---|---|---|
Net sales | 2.5B 349M 298M 278M 258M 477M 29.92B 531M 3.33B 1.27B 14.01B 1.31B 1.28B 51.39B | 2.75B 383M 328M 305M 284M 524M 32.87B 583M 3.66B 1.4B 15.39B 1.44B 1.41B 56.44B |
Net income | 187M 26.07M 22.3M 20.77M 19.32M 35.69M 2.24B 39.66M 249M 95.14M 1.05B 97.79M 95.77M 3.84B | 232M 32.32M 27.64M 25.74M 23.94M 44.24M 2.77B 49.17M 308M 118M 1.3B 121M 119M 4.76B |
Net Debt | - | - |
More financial data
* Estimated data
Employees
2,476
Sector
Pharmaceuticals
Calendar
Date | Price | Change | Volume |
---|---|---|---|
25-07-11 | 6.980 ¥ | +0.14% | 53,648,900 |
25-07-10 | 6.970 ¥ | +4.03% | 92,318,500 |
25-07-09 | 6.700 ¥ | -2.05% | 54,847,620 |
25-07-08 | 6.840 ¥ | +3.48% | 88,246,590 |
25-07-07 | 6.610 ¥ | +5.25% | 86,188,070 |
End-of-day quote Shenzhen S.E., July 10, 2025
More quotesSell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
6.980
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Equities
- 002688 Stock
Select your edition
All financial news and data tailored to specific country editions